Key result
The non-MRA fraction derived from ultrasound envelope statistical analysis positively correlated with steatosis progression (r = 0.458, p < 0.001), enabling simultaneous evaluation of fat and fibrosis.
Why the study?
Few studies have reported the simultaneous evaluation of both lipid droplets and fibrotic tissue in patients whose livers contain adipose and fibrous features.
Does an analytical method combining the MRA model and HLSF accurately estimate fat and fibrotic volumes in patients with fatty liver?
Observational (n=204)
No
Does an analytical method combining the MRA model and HLSF accurately estimate fat and fibrotic volumes in patients with fatty liver?
Effect estimate: r = 0.458
p-value: p=<0.001
A novel ultrasound analytical method combining a multi-Rayleigh model and a healthy liver structure filter can simultaneously evaluate fat mass and fibrosis progression in early fatty liver.
May support noninvasive simultaneous steatosis-fibrosis assessment by ultrasound; leaves open prospective validation before clinical use.
PURPOSE: Quantitative diagnosis of the degree of fibrosis progression is currently a focus of attention for fatty liver in nonalcoholic steatohepatitis (NASH). However, previous studies have focused on either lipid droplets or fibrotic tissue, and few have reported the evaluation of both in patients whose livers contain adipose and fibrous features. Our aim was to evaluate fibrosis tissue and lipid droplets in the liver. METHODS: We used an analytical method combining the multi-Rayleigh (MRA) model and a healthy liver structure filter (HLSF) as a technique for statistical analysis of the amplitude envelope to estimate fat and fibrotic volumes in clinical datasets with different degrees of fat and fibrosis progression. RESULTS: Fat mass was estimated based on the non-MRA fraction corresponding to the signal characteristics of aggregated lipid droplets. Non-MRA fraction has a positive correlation with fat mass and is effective for detecting moderate and severe fatty livers. Progression of fibrosis was estimated using MRA parameters in combination with the HLSF. The proposed method was used to extract non-healthy areas with characteristics of fibrotic tissue. Fibrosis in early fatty liver suggested the possibility of evaluation. On the other hand, fat was identified as a factor that reduced the accuracy of estimating fibrosis progression in moderate and severe fatty livers. CONCLUSION: The proposed method was used to simultaneously evaluate fat mass and fibrosis progression in early fatty liver, suggesting the possibility of quantitative evaluation for discriminating between lipid droplets and fibrous tissue in the early fatty liver.
No takes yet. Share an insight, caveat, or question.
Ujihara et al. (2023) conducted an observational in Liver steatosis and fibrosis in chronic hepatitis B or C (n=204). Modified multi-Rayleigh (MRA) model and healthy liver structure filter (HLSF) ultrasound analysis vs. Histopathological evaluation was evaluated on Correlation between non-MRA fraction and steatosis progression (r = 0.458, p=<0.001). The non-MRA fraction derived from ultrasound envelope statistical analysis positively correlated with steatosis progression (r = 0.458, p < 0.001), enabling simultaneous evaluation of fat and fibrosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: